ACCESS! 2026 Day 2 Recap
ACCESS! 2026 Day 2 Recap: New Leadership, Hard Data, and a View from the Top After a memorable first evening capped by a Candlelight by Fever performance that traded policy debates for strings and candlelight, ACCESS! 2026 attendees returned to the plenary hall Wednesday morning energized and ready for a second day packed with substance. […]
ACCESS! 2026 Day 1 Recap
ACCESS! 2026 Day 1 Recap: Weathering Every Storm to Protect Patient Access Leaders and luminaries in the generic and biosimilars community descended on Miami for the opening day of ACCESS! 2026, many having braved a historic blizzard slamming the Northeast to reach the sunshine. While the determination of those who made it underscored the industry’s […]
Mark Your Calendar for Access! 2026
Mark your calendar for February 23–25, 2026, and join us at the JW Marriott Miami Turnberry Resort & Spa for a can’t-miss event bringing together top minds from across the generics and biosimilars industry. Whether you’re a seasoned expert or emerging leader, this is your chance to gain fresh insights, make valuable connections, and be […]
Access! 2024 – Charting a Sustainable Path for Generics and Biosimilars
Access! 2024, held in Tampa, FL from February 5–7, 2024, was a pivotal gathering for the generics and biosimilars industry, bringing together thought leaders and stakeholders to chart a sustainable path for the future. To mark the commencement of Access! 2024, AAM’s Interim President & CEO, David Gaugh, RPh, delivered his welcome remarks. His address […]
Join Us at Access! 2024 in Tampa, Florida
Access! 2024 – AAM Annual Meeting February 5–7, 2024 JW Marriott Tampa Water Street, Tampa, Florida AAM’s annual meeting Access! 2024 brings together policymakers, influential speakers and industry leaders to chart the future of generics and biosimilars. Discussions center around the business, breakthroughs and politics that shape our industry. It’s the opportunity to hear firsthand […]
A Look Back at Access! 2023
Each year, we look forward to hosting our members, friends, colleagues and partners for Access!, AAM’s annual meeting. Held in Orlando, Florida, this year’s conference was unique in that we also hosted the 25th Annual Meeting of the International Generic and Biosimilar Medicines Association (IGBA) in the same location, a dual experience that helped to […]
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder.
Entrepreneur and founder of the Mark Cuban Cost Plus Drug Company, PBC, Mark Cuban, sat down with our new Board Chair Christine Baeder, SVP, COO for US Generics at Teva Pharmaceuticals, to discuss his efforts to reduce #drugprices and increase competition in the drug market. #Access2023 #drugprices #patientaccess
Join Us at Access! 2023
Access! 2023 – AAM Annual Meeting and 25th IGBA Annual Conference February 13-16, 2023 JW Marriott Orlando Bonnet Creek Resort & Spa Orlando, Florida Two Conferences—One Location! This year, the Association for Accessible Medicines (AAM) is hosting two annual meetings—AAM’s Annual Meeting Access! and the International Generic and Biosimilar Medicines Association (IGBA) Annual Conference—in […]
Access! 2022: Recapping AAM’s Annual Meeting
Access is literally our middle name, CEO Dan Leonard reminded attendees at Access! 2022, the Association for Accessible Medicine’s first in-person conference in two years. The two-day event in Orlando, Fla., brought together a range of leaders from government and industry to discuss the challenges, responsibilities and future of generics and biosimilars. In his remarks […]
Access! 2021 Recap: Day Two
All of us here today have the ability and the opportunity to change the lives of hundreds of millions of people, declared Dan Leonard, CEO of the Association for Accessible Medicines on May 27, the second day of Access!—AAM’s signature annual event. I am optimistic, his state of AAM address continued, because this industry has […]
Access! 2021 Recap: Day One
Access! 2021, the annual meeting of the Association for Accessible Medicines (AAM), took place May 26 and 27, bringing together health care and industry leaders from around the country and around the world. The virtual conference convened amidst a background of continued progress in the United States against the COVID-19 pandemic, and some global setbacks and […]
Message from CEO Dan Leonard on Access! 2021
Dan Leonard, President and CEO of the Association for Accessible Medicines (AAM) personally invites leaders in the generics and biosimilars industry to join the AAM annual meeting on May 26-27. Learn more or register at: https://access.accessiblemeds.org/
